Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis

doi:10.3969/j.issn.1000-6621.2020.09.015

Abstract

Abstract:

Objective To observe the treatment efficacy of drug transdermal delivery by electro-phonophoresis combined with oral anti-tuberculosis drugs in patients with tuberculosis of chest wall. Methods The prospective research method was adopted. A total of 192 patients with tuberculosis of chest wall, who received initial anti-tuberculosis treatment in the Beijing Chest Hospital from July 2012 to February 2019, were enrolled into this study. Using the random number table, those patients were randomly divided into two groups: orally taking anti-tuberculosis drugs (2H-R-Z-E/7H-R-E)+ultrasonic transdermal delivery of isoniazid and rifampin (abbreviated as “EP group”); orally taking anti-tuberculosis drugs (2H-R-Z-E/7H-R-E; abbreviated as “control group”). There were 97 patients in the EP group, 2 patients lost follow-up, and finally 95 patients were evaluated; 95 patients were enrolled in the control group, 10 patients lost follow-up, and finally 85 patients were evaluated. The therapeutic effects of the patients with chest wall tuberculosis in the two groups receiving different treatment schemes were analyzed. Results In the EP group, 64 patients were cured and the treatment efficacy was significant in additional 13 patients, so the total treatment effective rate was 81.1% (77/95). In the control group, 18 patients were cured and the treatment efficacy was significant in 2 patients, so the total treatment effective rate was 23.5% (20/85). The total treatment effective rate of the patients in the EP group was higher than that in the control group, and the difference was statistically significant (χ²=59.738, P<0.001). Conclusion The therapeutic effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drugs treatment in the patients with chest wall tuberculosis is much better than that of traditional treatment only with oral anti-tuberculosis drugs, and it can be used as an adjuvant treatment method in the patients with chest wall tuberculosis in their perioperative period.

Key words: Thoracic wall, Tuberculosis, Drug therapy, Phonophoresis, Comparative study

MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972. doi: 10.3969/j.issn.1000-6621.2020.09.015

Figures/Tables 4

References 23

[1]	Subotic D, Yablonskiy P, Sulis G, et al. Surgery and pleuro-pulmonary tuberculosis: a scientific literature review. J Thorac Dis, 2016,8(7):E474-485. doi: 10.21037/jtd.2016.05.59. URL pmid: 27499980
[2]	姜友定, 陈穗, 江涛. 346例胸壁结核脓肿的治疗总结并文献复习. 中华胸心血管外科杂志, 2014,30(7):417-418. doi: 10.3760/cma.j.issn.1001-4497.2014.07.010.
[3]	周玲霞, 金红玉, 楼敏, 等. 不同干预策略对胸壁结核易复发因素的研究. 中华医院感染学杂志, 2015,25(13):3031-3033. doi: 10.11816/cn.ni.2015-141542.
[4]	万荣, 李明武, 朱惠琼, 等. 抗结核药物超声导入治疗淋巴结结核的临床观察. 云南医药, 2016,37(6):649-651.
[5]	梁子坤, 邓玲, 刘志东, 等. 超声药物电导入治疗颈部淋巴结结核. 中国医药, 2014,9(10):1517-1519. doi: 10.3760/cma.j.issn.1673-4777.2014.10.032.
[6]	汪亚芬, 王姬, 谢固雅, 等. 中药超声电导靶位透入联合抗结核化疗治疗颈淋巴结结核的疗效观察. 中国中西医结合杂志, 2018,38(4):425-429. doi: 10.7661/j.cjim.20180224.062.
[7]	张志庸. 协和胸外科学. 2版. 北京: 科学出版社, 2010: 5.
[8]	吴英恺. 胸部外科. 北京: 人民卫生出版社, 1974: 282-283.
[9]	Deng B, Tan QY, Wang RW, et al. Surgical strategy for tubercular abscess in the chest wall: experience of 120 cases. Eur J Cardiothorac Surg, 2012,41(6):1349-1352. doi: 10.1093/ejcts/ezr209. doi: 10.1093/ejcts/ezr209 URL pmid: 22241003
[10]	Sevgi DY, Derin O, Alpay AS, et al. Extrapulmonary tuberculosis: 7 year-experience of a tertiary center in Istanbul. Eur J Intern Med, 2013,24(8):864-867. doi: 10.1016/j.ejim.2013.08.704. doi: 10.1016/j.ejim.2013.08.704 URL pmid: 24028930
[11]	Massard G, Olland A, Santelmo N, et al. Surgery for the sequelae of postprimary tuberculosis. Thorac Surg Clin, 2012,22(3):287-300. doi: 10.1016/j.thorsurg.2012.05.006. doi: 10.1016/j.thorsurg.2012.05.006 URL pmid: 22789594
[12]	赵吉庆, 郑文文. 探讨内科抗结核联合择机手术治疗胸壁结核的效果及复发情况. 中国实用医刊, 2014,41(15):78-79. doi: 10.3760/cma.j.issn.1674-4756.2014.15.035.
[13]	蒋良双, 伍伫, 吴邦责, 等. 胸壁结核的诊断和外科治疗之探讨. 四川医学, 2011,32(10):1567-1569. doi: 10.3969/j.issn.1004-0501.2011.10.027.
[14]	Madansein R, Parida S, Padayatchi N, et al. Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis. Int J Infect Dis, 2015,32:61-67. doi: 10.1016/j.ijid.2015.01.019. doi: 10.1016/j.ijid.2015.01.019 URL pmid: 25809758
[15]	于大平, 韩毅, 刘志东. 外科手术治疗慢性结核性脓胸的临床疗效观察. 中华医学杂志, 2014,94(31):2441-2443. doi: 10.3760/cma.j.issn.0376-2491.2014.31.012.
[16]	Han YI, Zhao Q, Yu D, et al. Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery. Exp Ther Med, 2015,9(4):1433-1437. doi: 10.3892/etm.2015.2219. doi: 10.3892/etm.2015.2219 URL pmid: 25780447
[17]	李良成, 张永顺, 李忠红. 超声药物促渗设备的研制. 生物医学工程学杂志, 2009,26(1):184-186.
[18]	Ninomiya K, Kawabata S, Tashita H, et al. Ultrasound-mediated drug delivery using liposomes modified with a thermosensitive polymer. Ultrason Sonochem, 2014,21(1):310-316. doi: 10.1016/j.ultsonch.2013.07.014. doi: 10.1016/j.ultsonch.2013.07.014 URL pmid: 23948493
[19]	Sutton JT, Haworth KJ, Pyne-Geithman G, et al. Ultrasound-mediated drug delivery for cardiovascular disease. Expert Opin Drug Deliv, 2013,10(5):573-592. doi: 10.1517/17425247.2013.772578. doi: 10.1517/17425247.2013.772578 URL pmid: 23448121
[20]	Chen S, Han Y, Yu D, et al. Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis. Drug Deliv, 2017,24(1):467-470. doi: 10.1080/10717544.2016.1267275. URL pmid: 28181840
[21]	Schoellhammer CM, Polat BE, Mendenhall J, et al. Rapid skin permeabilization by the simultaneous application of dual-frequency, high-intensity ultrasound. J Control Release, 2012,163(2):154-160. doi: 10.1016/j.jconrel.2012.08.019. doi: 10.1016/j.jconrel.2012.08.019 URL pmid: 22940128
[22]	Polat BE, Figueroa PL, Blankschtein D, et al. Transport pathways and enhancement mechanisms within localized and non-localized transport regions in skin treated with low-frequency sonophoresis and sodium lauryl sulfate. J Pharm Sci, 2011,100(2):512-529. doi: 10.1002/jps.22280. doi: 10.1002/jps.22280 URL pmid: 20740667
[23]	Chen S, Qin M, Han Y, et al. Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis. Drug Deliv, 2016,23(5):1588-1593. doi: 10.3109/10717544.2015.1124474. URL pmid: 26669820

组别	治愈		显效		无效		总有效率^a (%)
组别	例数	构成比(%)	例数	构成比(%)	例数	构成比(%)	总有效率^a (%)
电导组(95例)	64	67.4	13	13.7	18	18.9	81.1
对照组(85例)	18	21.2	2	2.3	65	76.5	23.5